title: Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review.
abstract: To assess the effectiveness of ketorolac vs control for prevention of acute pseudophakic cystoid macular edema (CME). The following databases were searched: Medline (1950-June 11, 2011), The Cochrane Library (Issue 2, 2011), and the TRIP Database (up to 11 June 2011), using no language or other limits. Randomized controlled clinical trials (RCTs) were included that consisted of patients with acute pseudophakic cystoid macular edema, those comparing ketorolac with control, and those having at least a minimum follow-up of 28 days. In the four RCTs evaluating ketorolac vs control, treatment with ketorolac significantly reduced the risk of CME development at the end of treatment (≈ 4 weeks) compared to control (P=0.008; 95% confidence interval (0.03-0.58)). When analyzed individually, each individual study was statistically nonsignificant in its findings with the exception of one study. When the pooled relative risk was calculated, the large sample size of this systematic review led to overall statistical significance, which is attributable to the review's large sample size and not to the individual studies themselves. In this systematic review of four RCTs, two of which compared ketorolac with no treatment and two of which evaluated ketorolac vs placebo drops, treatment with ketorolac significantly reduced the risk of developing CME at the end of ≈ 4 weeks of treatment compared with controls. These results, however, should be interpreted with caution considering the paucity of large randomized clinical trials in the literature.
authors.affiliation: Department of Ophthalmology, Stony Brook University, NY 11733, USA. taygan.yilmaz@gmail.com
authors.forename: T
authors.initials: T
authors.lastname: Yilmaz
authors.forename: M
authors.initials: M
authors.lastname: Cordero-Coma
authors.forename: M J
authors.initials: MJ
authors.lastname: Gallagher
mesh_terms: D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D002387:Cataract Extraction / Q000009:adverse effects; D006801:Humans; D020910:Ketorolac / Q000008:administration & dosage / Q000627:therapeutic use*; D008269:Macular Edema / Q000188:drug therapy* / Q000517:prevention & control; D011183:Postoperative Complications / Q000517:prevention & control; D019591:Pseudophakia / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D014792:Visual Acuity
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D020910:Ketorolac
references.citation: Ophthalmology. 1990 Oct;97(10):1253-8
references.pmid: 2243674
references.citation: J Cataract Refract Surg. 2006 Sep;32(9):1474-82
references.pmid: 16931258
references.citation: Trans Am Ophthalmol Soc. 1998;96:557-634
references.pmid: 10360304
references.citation: Eur J Pharmacol. 1984 Nov 13;106(2):327-33
references.pmid: 6529979
references.citation: J Cataract Refract Surg. 2008 Jan;34(1):64-9
references.pmid: 18165083
references.citation: Br J Ophthalmol. 2005 Nov;89(11):1420-2
references.pmid: 16234444
references.citation: Ophthalmology. 1998 Mar;105(3):397-405
references.pmid: 9499767
references.citation: Ophthalmologica. 2011;225(2):89-94
references.pmid: 20881443
references.citation: BMJ. 1994 Nov 12;309(6964):1286-91
references.pmid: 7718048
references.citation: J Med Invest. 2009 Feb;56(1-2):11-5
references.pmid: 19262008
references.citation: Am J Ophthalmol. 2008 Oct;146(4):554-560
references.pmid: 18599019
references.citation: Drug Saf. 2002;25(4):233-50
references.pmid: 11994027
references.citation: Control Clin Trials. 1996 Feb;17(1):1-12
references.pmid: 8721797
references.citation: J Cataract Refract Surg. 2003 Dec;29(12):2378-84
references.pmid: 14709300
references.citation: JAMA. 2003 Aug 20;290(7):921-8
references.pmid: 12928469
references.citation: Ophthalmology. 2008 Feb;115(2):412-3; author reply 413
references.pmid: 18243910
references.citation: Doc Ophthalmol. 1999;97(3-4):297-309
references.pmid: 10896343
references.citation: Am J Ophthalmol. 1987 Apr 15;103(4):479-86
references.pmid: 3551617
references.citation: Ophthalmology. 1987 May;94(5):461-6
references.pmid: 3601359
references.citation: Ophthalmology. 2022 Jan;129(1):P1-P126
references.pmid: 34780842
references.citation: Dev Ophthalmol. 2010;47:148-159
references.pmid: 20703048